Animal models of rheumatoid arthritis: How informative are they?

European Journal of Pharmacology

Volumn 759, Issue , 2015, Pages 278-286

  McNamee, Kay ^a   Williams, Richard ^a   Seed, Michael ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF EAST LONDON   (United Kingdom)

Author keywords

Keywords Rheumatoid arthritis Animal models Drug therapy Biologics

Indexed keywords

ANTIRHEUMATIC AGENT; AUTOANTIBODY; RHEUMATOID FACTOR;

ANIMAL; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; BLOOD; GENETICS; HUMAN; IMMUNOLOGY; JOINT; PATHOLOGY; PRECLINICAL STUDY; PROCEDURES;

ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; DRUG EVALUATION, PRECLINICAL; HUMANS; JOINTS; RHEUMATOID FACTOR;

EID: 84937763351     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.03.047     Document Type: Review

References (120)

1. S. Alzabin, S.M. Abraham, T.E. Taher, A. Palfreeman, D. Hull, K.E. McNamee, A. Jawad, E. Pathan, A. Kinderlerer, P.C. Taylor, R.O. Williams, and R. Mageed Incomplete response of inflammatory arthritis to TNFα blockade is associated with the Th17 pathway Ann. Rheum. Dis. 71 2012 1741 1748
2. S. Alzabin, and R.O. Williams Effector T cells in rheumatoid arthritis: lessons from animal models FEBS Lett. 585 2011 3649 3659
3. J. Backlund, C. Li, E. Jansson, S. Carlsen, P. Merky, K.S. Nandakumar, S. Haag, J. Ytterberg, R.A. Zubarev, and R. Holmdahl C57BL/6 mice need MHC class II Aq to develop collagen-induced arthritis dependent on autoreactive T cells Ann. Rheum. Dis. 72 2013 1225 1232
4. A.E. Bedwell, C.J. Elson, and C.E. Hinton Immunological involvement in the pathogenesis of pristane-induced arthritis Scand. J. Immunol. 25 1987 393 398
5. E. Bettelli, Y. Carrier, W. Gao, T. Korn, T.B. Strom, M. Oukka, H.L. Weiner, and V.K. Kuchroo Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells Nature 441 2006 235 238
6. L. Bevaart, M.J. Vervoordeldonk, and P.P. Tak Evaluation of therapeutic targets in animal models of arthritis: how does it relate to rheumatoid arthritis? Arthritis Rheum. 62 2010 2192 2205
7. B.A. Binstadt, J.L. Hebert, A. Ortiz-Lopez, R. Bronson, C. Benoist, and D. Mathis The same systemic autoimmune disease provokes arthritis and endocarditis via distinct mechanisms Proc. Natl. Acad. Sci. USA 106 2009 16758 16763
8. D. Brackertz, G.F. Mitchell, and I.R. Mackay Antigen-induced arthritis in mice. I. Induction of arthritis in various strains of mice Arthritis Rheum. 20 1977 841 850
9. F.M. Brennan, D. Chantry, A. Jackson, R. Maini, and M. Feldmann Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis Lancet 2 1989 244 247
10. M.H. Buch, S.J. Bingham, D. Bryer, and P. Emery Long-term infliximab treatment in rheumatoid arthritis: subsequent outcome of initial responders Rheumatology 46 2007 1153 1156
11. I.K. Campbell, J.A. Hamilton, and I.P. Wicks Collagen-induced arthritis in C57BL/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis Eur. J. Immunol. 30 2000 1568 1575
12. S. Cemerski, S.Y. Chu, E. Pong, H.M. Horton, J.R. Desjarlais, and D.E. Szymkowski Suppression of collagen-induced arthritis in mice by anti-CD19 antibody that co-engages BCR and inhibitory receptor FcRIIb: efficacy does not require B cell depletion Arthritis Rheum. 62 Suppl. 10 2010 S1350 [abstract]
13. D.Y. Chen, Y.M. Chen, H.H. Chen, C.W. Hsieh, C.C. Lin, and J.L. Lan Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-alpha therapy Arthritis Res. Ther. 13 2011 R126
14. X. Chen, M. Baumel, D.N. Mannel, O.M. Howard, and J.J. Oppenheim Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells J. Immunol. 179 2007 154 161
15. C.A. Christianson, M. Corr, T.L. Yaksh, and C.I. Svensson K/BxN serum transfer arthritis as a model of inflammatory joint pain Methods Mol. Biol. 851 2012 249 260
16. M. Cojocaru, I.M. Cojocaru, I. Silosi, C.D. Vrabie, and R. Tanasescu Extra-articular manifestations in rheumatoid arthritis Maedica 5 2010 286 291
17. M. Corr, and B. Crain The role of FcgammaR signaling in the K/BxN serum transfer model of arthritis J. Immunol. 169 2002 6604 6609
18. M. Cutolo, and M. Meroni Clinical utility of the oral JAK inhibitor tofacitinib in the treatment of rheumatoid arthritis J. Inflamm. Res. 6 2013 129 137
19. H.J. Ditzel The K/BxN mouse: a model of human inflammatory arthritis Trends Mol. Med. 10 2004 40 45
20. T. Dorner, K. Egerer, E. Feist, and G.R. Burmester Rheumatoid factor revisited Curr. Opin. Rheumatol. 16 2004 246 253
21. T. Dorner, and A. Hansen Autoantibodies in normals - the value of predicting rheumatoid arthritis Arthritis Res. Ther. 6 2004 282 284
22. D.C. Dumonde, and L.E. Glynn The production of arthritis in rabbits by an immunological reaction to fibrin Br. J. Exp. Pathol. 43 1962 373 383
23. M.R. Ehrenstein, J.G. Evans, A. Singh, S. Moore, G. Warnes, D.A. Isenberg, and C. Mauri Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy J. Exp. Med. 200 2004 277 285
24. R.M. Fleischmann Rheumatoid arthritis: developing new oral targeted therapies for RA can be challenging Nat. Rev. Rheumatol. 11 2015 4 6
25. M. Forster, B. Raposo, D. Ekman, D. Klaczkowska, M. Popovic, K.S. Nandakumar, T. Lindvall, M. Hultqvist, I. Teneva, M. Johannesson, E. Ahlqvist, and R. Holmdahl Genetic control of antibody production during collagen-induced arthritis development in heterogeneous stock mice Arthritis Rheum. 64 2012 3594 3603
26. F. Franco, G.D. Thomas, B. Giroir, D. Bryant, M.C. Bullock, M.C. Chwialkowski, R.G. Victor, and R.M. Peshock Magnetic resonance imaging and invasive evaluation of development of heart failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha Circulation 99 1999 448 454
27. M. Fujimoto, S. Serada, M. Mihara, Y. Uchiyama, H. Yoshida, N. Koike, Y. Ohsugi, T. Nishikawa, B. Ripley, A. Kimura, T. Kishimoto, and T. Naka Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses Arthritis Rheum. 58 2008 3710 3719
28. M. Fujita, J.M. Shannon, C.G. Irvin, K.A. Fagan, C. Cool, A. Augustin, and R.J. Mason Overexpression of tumor necrosis factor-alpha produces an increase in lung volumes and pulmonary hypertension Am. J. Physiol. Lung Cell. Mol. Physiol. 280 2001 L39 L49
29. K. Garber Pfizer's JAK inhibitor sails through phase 3 in rheumatoid arthritis Nat. Biotechnol. 29 2011 467 468
30. M.C. Genovese, P. Durez, H.B. Richards, J. Supronik, E. Dokoupilova, V. Mazurov, J.A. Aelion, S.H. Lee, C.E. Codding, H. Kellner, T. Ikawa, S. Hugot, and S. Mpofu Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study Ann. Rheum. Dis. 72 2013 863 869
31. P.K. Gregersen, J. Silver, and R.J. Winchester The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis Arthritis Rheum. 30 1987 1205 1213
32. D. Hammaker, and G.S. Firestein "Go upstream, young man": lessons learned from the p38 saga Ann. Rheum. Dis. 69 Suppl. 1 2010 i77 i82
33. C. Haworth, F.M. Brennan, D. Chantry, M. Turner, R.N. Maini, and M. Feldmann Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-a Eur. J. Immunol. 21 1991 2575 2579
34. M. Hay, D.W. Thomas, J.L. Craighead, C. Economides, and J. Rosenthal Clinical development success rates for investigational drugs Nat. Biotechnol. 32 2014 40 51
35. A.H. Hensvold, P.K. Magnusson, V. Joshua, M. Hansson, L. Israelsson, R. Ferreira, P.J. Jakobsson, R. Holmdahl, L. Hammarstrom, V. Malmstrom, J. Askling, L. Klareskog, and A.I. Catrina Environmental and genetic factors in the development of anticitrullinated protein antibodies (ACPAs) and ACPA-positive rheumatoid arthritis: an epidemiological investigation in twins Ann. Rheum. Dis. 74 2015 375 380
36. T. Hirano, T. Matsuda, M. Turner, N. Miyasaka, G. Buchan, B. Tang, K. Sato, M. Shimizu, R. Maini, and M. Feldmann Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis Eur. J. Immunol. 18 1988 1797 1801
37. K. Hirota, M. Hashimoto, H. Yoshitomi, S. Tanaka, T. Nomura, T. Yamaguchi, Y. Iwakura, N. Sakaguchi, and S. Sakaguchi T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis J. Exp. Med. 204 2007 41 47
38. R. Holmdahl, M.E. Andersson, T.J. Goldschmidt, L. Jansson, M. Karlsson, V. Malmström, and J. Mo Collagen induced arthritis as an experimental model for rheumatoid arthritis. Immunogenetics, pathogenesis and autoimmunity Acta Pathol. Microbiol. Immunol. Scand. 97 1989 575 584
39. R. Holmdahl, T.J. Goldschmidt, S. Kleinau, C. Kvick, and R. Jonsson Arthritis induced in rats with adjuvant oil is a genetically restricted, alpha beta T-cell dependent autoimmune disease Immunology 76 1992 197 202
40. F.A. Houssiau, J.P. Devogelaer, J. Van Damme, C.N. de Deuxchaisnes, and J. Van Snick Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides Arthritis Rheum. 31 1988 784 788
41. L.Y. Hsu, Y.X. Tan, Z. Xiao, M. Malissen, and A. Weiss A hypomorphic allele of ZAP-70 reveals a distinct thymic threshold for autoimmune disease versus autoimmune reactivity J. Exp. Med. 206 2009 2527 2541
42. J.J. Inglis, G. Criado, M. Medghalchi, M. Andrews, A. Sandison, M. Feldmann, and R.O. Williams Collagen-Induced Arthritis in C57BL/6 mice is associated with a robust and sustained T-cell response to type II collagen Arthritis Res. Ther. 9 2007 R113
43. J.J. Inglis, C.A. Notley, D. Essex, A.W. Wilson, M. Feldmann, P. Anand, and R. Williams Collagen-induced arthritis as a model of hyperalgesia: functional and cellular analysis of the analgesic actions of tumor necrosis factor blockade Arthritis Rheum. 56 2007 4015 4023
44. J.P. Jacobs, H.J. Wu, C. Benoist, and D. Mathis IL-17-producing T cells can augment autoantibody-induced arthritis Proc. Natl. Acad. Sci. USA 106 2009 21789 21794
45. G. Janossy, G. Panayi, O. Duke, M. Bofill, L.W. Poulter, and G. Goldstein Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation Lancet 2 1981 839 842
46. B. Joe, G.W. Cannon, M.M. Griffiths, D.E. Dobbins, P.S. Gulko, R.L. Wilder, and E.F. Remmers Evaluation of quantitative trait loci regulating severity of mycobacterial adjuvant-induced arthritis in monocongenic and polycongenic rats: identification of a new regulatory locus on rat chromosome 10 and evidence of overlap with rheumatoid arthritis susceptibility loci Arthritis Rheum. 46 2002 1075 1085
47. J. Keffer, L. Probert, H. Cazlaris, S. Georgopoulos, E. Kaslaris, D. Kioussis, and G. Kollias Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis EMBO J. 10 1991 4025 4031
48. R.C. Keith, J.L. Powers, E.F. Redente, A. Sergew, R.J. Martin, A. Gizinski, V.M. Holers, S. Sakaguchi, and D.W. Riches A novel model of rheumatoid arthritis-associated interstitial lung disease in SKG mice Exp. Lung Res. 38 2012 55 66
49. R.C. Keith, J. Sokolove, B.L. Edelman, L. Lahey, E.F. Redente, V.M. Holers, S. Sakaguchi, W.H. Robinson, and D.W. Riches Testosterone is protective in the sexually dimorphic development of arthritis and lung disease in SKG mice Arthritis Rheum. 65 2013 1487 1493
50. E. Keystone Treatments no longer in development for rheumatoid arthritis Ann. Rheum. Dis. 61 Suppl 2 2002 ii43 ii45
51. L. Klareskog, J. Ronnelid, K. Lundberg, L. Padyukov, and L. Alfredsson Immunity to citrullinated proteins in rheumatoid arthritis Annu. Rev. Immunol. 26 2008 651 675
52. D.B. Knoerzer, R.W. Karr, B.D. Schwartz, and L.J. Mengle-Gaw Collagen-induced arthritis in the BB rat. Prevention of disease by treatment with CTLA-4-Ig J. Clin. Investig. 96 1995 987 993
53. T. Kobezda, S. Ghassemi-Nejad, K. Mikecz, T.T. Glant, and Z. Szekanecz Of mice and men: how animal models advance our understanding of T-cell function in RA Nat. Rev. Rheumatol. 10 2014 160 170
54. O. Kohashi, K. Aihara, A. Ozawa, S. Kotani, and I. Azuma New model of a synthetic adjuvant, N-acetylmuramyl-l-alanyl-d-isoglutamine- induced arthritis: clinical and histologic studies in athymic nude and euthymic rats Lab. Investig. 47 1982 27 36
55. A.S. Korganow, H. Ji, S. Mangialaio, V. Duchatelle, R. Pelanda, T. Martin, C. Degott, H. Kikutani, K. Rajewsky, J.L. Pasquali, C. Benoist, and D. Mathis From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins Immunity 10 1999 451 461
56. T. Korn, E. Bettelli, M. Oukka, and V.K. Kuchroo IL-17 and Th17 Cells Annu. Rev. Immunol. 27 2009 485 517
57. V. Kouskoff, A.S. Korganow, V. Duchatelle, C. Degott, C. Benoist, and D. Mathis Organ-specific disease provoked by systemic autoimmunity Cell 87 1996 811 822
58. P. Larsson, R. Holmdahl, L. Dencker, and L. Klareskog In vivo treatment with W3/13 (anti-pan T) but not with OX8 (anti-suppressor/cytotoxic T) monoclonal antibodies impedes the development of adjuvant arthritis in rats Immunology 56 1985 383 391
59. C. Liu, J. Lin, G. Everlof, C. Gesenberg, H. Zhang, P.H. Marathe, M. Malley, M.A. Galella, M. McKinnon, J.H. Dodd, J.C. Barrish, G.L. Schieven, and K. Leftheris Synthesis and evaluation of carbamoylmethylene linked prodrugs of BMS-582949, a clinical p38alpha inhibitor Bioorg. Med. Chem. Lett. 23 2013 3028 3033
60. Y. Liu, E.Q. Wu, A.G. Bensimon, C.P. Fan, Y. Bao, A. Ganguli, M. Yang, M. Cifaldi, and P. Mulani Cost per responder associated with biologic therapies for Crohn's disease, psoriasis, and rheumatoid arthritis Adv. Ther. 29 2012 620 634
61. J.C. Lorentzen, and L. Klareskog Susceptibility of DA rats to arthritis induced with adjuvant oil or rat collagen is determined by genes both within and outside the major histocompatibility complex Scand. J. Immunol. 44 1996 592 598
62. E. Lubberts, M.I. Koenders, B. Oppers-Walgreen, L. van den Bersselaar, C.J. Coenen-de Roo, L.A. Joosten, and W.B. van den Berg Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion Arthritis Rheum. 50 2004 650 659
63. K. Lundberg, S. Nijenhuis, E.R. Vossenaar, K. Palmblad, W.J. van Venrooij, L. Klareskog, A.J. Zendman, and H.E. Harris Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity Arthritis Res. Ther. 7 2005 R458 R467
64. H. Mahdi, B.A. Fisher, H. Kallberg, D. Plant, V. Malmstrom, J. Ronnelid, P. Charles, B. Ding, L. Alfredsson, L. Padyukov, D.P. Symmons, P.J. Venables, L. Klareskog, and K. Lundberg Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis Nat. Genet. 41 2009 1319 1324
65. R.N. Maini, F.C. Breedveld, J.R. Kalden, J.S. Smolen, D. Davis, J.D. Macfarlane, C. Antoni, B. Leeb, M.J. Elliott, J.N. Woody, T.F. Schaible, and M. Feldmann Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis Arthritis Rheum. 41 1998 1552 1563
66. S. Mangialaio, H. Ji, A.S. Korganow, V. Kouskoff, C. Benoist, and D. Mathis The arthritogenic T cell receptor and its ligand in a model of spontaneous arthritis Arthritis Rheum. 42 1999 2517 2523
67. I. Matsumoto, A. Staub, C. Benoist, and D. Mathis Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme Science 286 1999 1732 1735
68. C. Mauri, R.O. Williams, M. Walmsley, and M. Feldmann Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis Eur. J. Immunol. 26 1996 1511 1518
69. F.E. McCann, A.C. Palfreeman, M. Andrews, D.P. Perocheau, J.J. Inglis, P. Schafer, M. Feldmann, R.O. Williams, and F.M. Brennan Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis Arthritis Res. Ther. 12 2010 R107
70. F.E. McCann, D.P. Perocheau, G. Ruspi, K. Blazek, M.L. Davies, M. Feldmann, J.L. Dean, A.A. Stoop, and R.O. Williams Selective tumor necrosis factor receptor I blockade is antiinflammatory and reveals immunoregulatory role of tumor necrosis factor receptor II in collagen-induced arthritis Arthritis Rheumatol. 66 2014 2728 2738
71. I.B. McInnes, and G. Schett Cytokines in the pathogenesis of rheumatoid arthritis Nat. Rev. Immunol. 7 2007 429 442
72. M.E. Morgan, R. Flierman, L.M. van Duivenvoorde, H.J. Witteveen, W. van Ewijk, J.M. van Laar, R.R. de Vries, and R.E. Toes Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells Arthritis Rheum. 52 2005 2212 2221
73. C.A. Murphy, C.L. Langrish, Y. Chen, W. Blumenschein, T. McClanahan, R.A. Kastelein, J.D. Sedgwick, and D.J. Cua Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation J. Exp. Med. 198 2003 1951 1957
74. b congenic B10.Q mice J. Exp. Med. 180 1994 517 524
75. S. Nakae, A. Nambu, K. Sudo, and Y. Iwakura Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice J. Immunol. 171 2003 6173 6177
76. I. Navarro-Millan, J.A. Singh, and J.R. Curtis Systematic review of tocilizumab for rheumatoid arthritis: a new biologic agent targeting the interleukin-6 receptor Clin. Ther. 34 2012 788 802 e783
77. J.L. Newton, S.M. Harney, A.E. Timms, A.M. Sims, K. Rockett, C. Darke, B.P. Wordsworth, D. Kwiatkowski, and M.A. Brown Dissection of class III major histocompatibility complex haplotypes associated with rheumatoid arthritis Arthritis Rheum. 50 2004 2122 2129
78. J.L. Newton, S.M. Harney, B.P. Wordsworth, and M.A. Brown A review of the MHC genetics of rheumatoid arthritis Genes Immun. 5 2004 151 157
79. L.T. Nguyen, J. Jacobs, D. Mathis, and C. Benoist Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis Arthritis Rheum. 56 2007 509 520
80. C.A. Notley, J.J. Inglis, S. Alzabin, F.E. McCann, K.E. McNamee, and R.O. Williams Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells J. Exp. Med. 205 2008 2491 2497
81. C.P. Page, and D. Spina Phosphodiesterase inhibitors in the treatment of inflammatory diseases Handb. Exp. Pharmacol. 2011 391 414
82. A.C. Palfreeman, K.E. McNamee, and F.E. McCann New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast Drug Des. dev. Ther. 7 2013 201 210
83. H.B. Patel, B. Dawson, F. Humby, M. Blades, C. Pitzalis, M. Burnet, and M. Seed Animal models of rheumatoid arthritis C.N. Serhan, P.A. Ward, D.W. Gilroy, Fundamentals of Inflammation 2010 Cambridge Publications, Cambridge University Press Cambridge
84. C.M. Pearson Development of arthritis, periarthritis and periostitis in rats given adjuvants Proc. Soc. Exp. Biol. Med. 91 1956 95 101
85. C. Pitzalis, F. Humby, and M.P. Seed R.O. Watts, P.G. Conaghan, C. Denton, H. Foster, J. Isaacs, U. Müller-Ladner, Synovial Pathology 4th ed. 2013 Oxford Textbook of Rheumatology Oxford
86. C. Pitzalis, S. Kelly, and F. Humby New learnings on the pathophysiology of RA from synovial biopsies Curr. Opin. Rheumatol. 25 2013 334 344
87. M. Prete, V. Racanelli, L. Digiglio, A. Vacca, F. Dammacco, and F. Perosa Extra-articular manifestations of rheumatoid arthritis: an update Autoimmun. Rev. 11 2011 123 131
88. L. Probert, K. Akassoglou, L. Alexopoulou, E. Douni, S. Haralambous, S. Hill, G. Kassiotis, D. Kontoyiannis, M. Pasparakis, D. Plows, and G. Kollias Dissection of the pathologies induced by transmembrane and wild-type tumor necrosis factor in transgenic mice J. Leukoc. Biol. 59 1996 518 525
89. T. Robak, A. Gladalska, H. Stepien, and E. Robak Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis Mediat. Inflamm. 7 1998 347 353
90. N. Sakaguchi, T. Takahashi, H. Hata, T. Nomura, T. Tagami, S. Yamazaki, T. Sakihama, T. Matsutani, I. Negishi, S. Nakatsuru, and S. Sakaguchi Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice Nature 426 2003 454 460
91. G.L. Schieven Dual inhibition of p38 kinase activation and activity provides efficacy in treatment of rheumatoid arthritis Inflamm. Res. 61 2012 S7
92. M. Schiff Abatacept treatment for rheumatoid arthritis Rheumatology 50 2011 437 449
93. E. Schurgers, F. Mertens, J.A. Vanoirbeek, S. Put, T. Mitera, E. De Langhe, A. Billiau, P.H. Hoet, B. Nemery, E. Verbeken, and P. Matthys Pulmonary inflammation in mice with collagen-induced arthritis is conditioned by complete Freund's adjuvant and regulated by endogenous IFN-gamma Eur. J. Immunol. 42 2012 3223 3234
94. J.H. Schwab, R.R. Brown, S.K. Anderle, and P.M. Schlievert Superantigen can reactivate bacterial cell wall-induced arthritis J. Immunol. 150 1993 4151 4159
95. P.M. Seldon, P.J. Barnes, K. Meja, and M.A. Giembycz Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase Mol. Pharmacol. 48 1995 747 757
96. M.D. Siegel, D.H. Zhang, P. Ray, and A. Ray Activation of the interleukin-5 promoter by cAMP in murine EL-4 cells requires the GATA-3 and CLE0 elements J. Biol. Chem. 270 1995 24548 24555
97. A.J. Silman, and J.E. Pearson Epidemiology and genetics of rheumatoid arthritis Arthritis Res. 4 Suppl. 3 2002 S265 S272
98. I.G. Silveira, R.W. Burlingame, C.A. von Muhlen, A.L. Bender, and H.L. Staub Anti-CCP antibodies have more diagnostic impact than rheumatoid factor (RF) in a population tested for RF Clin. Rheumatol. 26 2007 1883 1889
99. O. Snir, M. Widhe, M. Hermansson, C. von Spee, J. Lindberg, S. Hensen, K. Lundberg, A. Engstrom, P.J. Venables, R.E. Toes, R. Holmdahl, L. Klareskog, and V. Malmstrom Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients Arthritis Rheum. 62 2010 44 52
100. S. Solomon, C. Kolb, S. Mohanty, E. Jeisy-Walder, R. Preyer, V. Schollhorn, and H. Illges Transmission of antibody-induced arthritis is independent of complement component 4 (C4) and the complement receptors 1 and 2 (CD21/35) Eur. J. Immunol. 32 2002 644 651
101. J. Stanczyk, C. Ospelt, and S. Gay Is there a future for small molecule drugs in the treatment of rheumatic diseases? Curr. Opin. Rheumatol. 20 2008 257 262
102. L. Svensson, J. Jirholt, R. Holmdahl, and L. Jansson B cell-deficient mice do not develop type II collagen-induced arthritis (CIA) Clin. Exp. Immunol. 111 1998 521 526
103. P.P. Tak, W. Rigby, A. Rubbert-Roth, C. Peterfy, R.F. van Vollenhoven, W. Stohl, E. Healy, E. Hessey, M. Reynard, and T. Shaw Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE Ann. Rheum. Dis. 71 2012 351 357
104. Z. Tang, B.S. McGowan, S.A. Huber, C.F. McTiernan, S. Addya, S. Surrey, T. Kubota, P. Fortina, Y. Higuchi, M.A. Diamond, D.S. Wyre, and A.M. Feldman Gene expression profiling during the transition to failure in TNF-alpha over-expressing mice demonstrates the development of autoimmune myocarditis J. Mol. Cell. Cardiol. 36 2004 515 530
105. J.A. Todd, H. Acha-Orbea, J.I. Bell, N. Chao, Z. Fronek, C.O. Jacob, M. McDermott, A.A. Sinha, L. Timmerman, and L. Steinman A molecular basis for MHC class II - associated autoimmunity Science 240 1988 1003 1009
106. E. Toubi, A. Kessel, Z. Mahmudov, K. Hallas, M. Rozenbaum, and I. Rosner Increased spontaneous apoptosis of CD4+CD25+ T cells in patients with active rheumatoid arthritis is reduced by infliximab Ann. NY Acad. Sci. 1051 2005 506 514
107. D.E. Trentham Collagen arthritis as a relevant model for rheumatoid arthritis: evidence pro and con Arthritis Rheum. 25 1982 911 916
108. W. van Eden, J.E. Thole, R. Van der Zee, A. Noordzij, J.D. van Embden, and I.R. Cohen Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis Nature 331 1988 171 173
109. T.L. Vincent, R.O. Williams, R. Maciewicz, A. Silman, P. Garside, and Arthritis Research UK animal models working group Mapping pathogenesis of arthritis through small animal models Rheumatology 51 2012 1931 1941
110. C. Vingsbo, R. Jonsson, and R. Holmdahl Avridine-induced arthritis in rats; a T cell-dependent chronic disease influenced both by MHC genes and by non-MHC genes Clin. Exp. Immunol. 99 1995 359 363
111. E.R. Vossenaar, S. Nijenhuis, M.M. Helsen, A. van der Heijden, T. Senshu, W.B. van den Berg, W.J. van Venrooij, and L.A. Joosten Citrullination of synovial proteins in murine models of rheumatoid arthritis Arthritis Rheum. 48 2003 2489 2500
112. W.C. Watson, J.P. Thompson, K. Terato, M.A. Cremer, and A.H. Kang Human HLA-DR beta gene hypervariable region homology in the biobreeding BB rat: selection of the diabetic-resistant subline as a rheumatoid arthritis research tool to characterize the immunopathologic response to human type II collagen J. Exp. Med. 172 1990 1331 1339
113. L.M. Webb, M.J. Walmsley, and M. Feldmann Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: requirement for both B7-1 and B7-2 Eur. J. Immunol. 26 1996 2320 2328
114. N. Wegner, R. Wait, A. Sroka, S. Eick, K.A. Nguyen, K. Lundberg, A. Kinloch, S. Culshaw, J. Potempa, and P.J. Venables Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and alpha-enolase: implications for autoimmunity in rheumatoid arthritis Arthritis Rheum. 62 2010 2662 2672
115. R.O. Williams Collagen-induced arthritis in mice Methods Mol. Med. 136 2007 191 199
116. R.O. Williams, M. Feldmann, and R.N. Maini Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis Proc. Natl. Acad. Sci. USA 89 1992 9784 9788
117. R.O. Williams, and A. Whyte Anti-CD4 monoclonal antibodies suppress murine collagen-induced arthritis only at the time of primary immunisation Cell. Immunol. 170 1996 291 295
118. S.T. Wrobleski, S. Lin, T.G. Dhar, A.J. Dyckman, T. Li, S. Pitt, R. Zhang, Y. Fan, A.M. Doweyko, J.S. Tokarski, K.F. Kish, S.E. Kiefer, J.S. Sack, J.A. Newitt, M.R. Witmer, M. McKinnon, J.C. Barrish, J.H. Dodd, G.L. Schieven, and K. Leftheris The identification of novel p38alpha isoform selective kinase inhibitors having an unprecedented p38alpha binding mode Bioorg. Med. Chem. Lett. 23 2013 4120 4126
119. K. Yanaba, Y. Hamaguchi, G.M. Venturi, D.A. Steeber St, E.W. Clair, and T.F. Tedder B cell depletion delays collagen-induced arthritis in mice: arthritis induction requires synergy between humoral and cell-mediated immunity J. Immunol. 179 2007 1369 1380
120. H. Yoshitomi, N. Sakaguchi, K. Kobayashi, G.D. Brown, T. Tagami, T. Sakihama, K. Hirota, S. Tanaka, T. Nomura, I. Miki, S. Gordon, S. Akira, T. Nakamura, and S. Sakaguchi A role for fungal β-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice J. Exp. Med. 201 2005 949 960